Concepedia

Xiaofan Li

XL

14

Publications

691

Citations

12

H-Index

2005

Active since

Affiliations

Sutro Biopharma (United States)(Current)

University of California, San Francisco

Xiaofan Li is an author at Sutro Biopharma (United States) specializing in medicine, drug discovery, and immunotherapy.

ORCID

Top concepts

Publications per year

2005–2023

14

Publications

14

Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System

Erik S. Zimmerman, Tyler H. Heibeck, Avinash Gill et al. · Bioconjugate Chemistry · 2014 · 350 citations

, , +23

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001

Cristina L. Abrahams, Xiaofan Li, Millicent Embry et al. · Oncotarget · 2018 · 51 citations · Full text

High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti‐CD74‐drug conjugate

Shuchun Zhao, Arturo Molina, Abigail Yu et al. · The Journal of Pathology Clinical Research · 2018 · 43 citations · Full text

Exploration of the carmaphycins as payloads in antibody drug conjugate anticancer agents

Jehad Almaliti, Bailey W. Miller, Halina Pietraszkiewicz et al. · European Journal of Medicinal Chemistry · 2018 · 43 citations

, , +7

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates

Gang Yin, Heather Stephenson, Junhao Yang et al. · Scientific Reports · 2017 · 38 citations · Full text

Rows per page

1–5 of 14